Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 39 antibodies PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


antibodies PhD Projects, Programmes & Scholarships

We have 39 antibodies PhD Projects, Programmes & Scholarships

Novel Immunotherapies and Vaccines for Virus Control

This is a Self-Funded/Sponsored PhD opportunity. FUNDING REQUIRED. Full UK/EU or International Tuition Fees. UK Living Expenses. Bench Fees (£68,500 total). Read more

Unlocking the genetic potential of barley by modulating recombination

Barley is a major worldwide crop used for malting and animal feed. However, breeding new varieties is constrained by the frequency of genetic crossovers (1-3 crossovers per chromosome pair) and their distribution (biased towards the chromosome ends) that underpin crop improvement1,2. Read more

Investigating the role of SUMOylation in meiotic recombination and chromosome segregation in Arabidopsis

Post-translational modifications of proteins such as phosphorylation, methylation and acetylation have been extensively studied in eukaryotes and now the Small Ubiquitin modifier (SUMO) is gaining attention for its importance in fundamental biological roles. Read more

Enhancing meiotic recombination in wheat by modulating RECQ helicases

Wheat accounts for 20% of the calories and protein consumed by humans and is the largest crop in the UK, but yields have plateaued and are susceptible to decline due to extreme weather conditions. Read more

Engineering Developable Biopharmaceuticals

The School of Molecular and Cellular Biology invites applications from prospective postgraduate researchers who wish to commence study for a PhD in the academic year 2024/25. Read more

Chemically Modified Therapeutic Nucleic Acids for Neurological Diseases

Therapeutic oligonucleotides are unique in targeting mRNA particularly those that cannot be addressed by conventional small molecule drugs or therapeutic antibodies, their potential is growing fast. Read more
Last chance to apply

Dissecting the interface between Klebsiella pneumoniae and lung immune cells in vivo and the effect of new therapeutics.

  Research Group: Wellcome-Wolfson Institute for Experimental Medicine
This collaborative PhD between GSK-Siena and the laboratory of Professor Jose Bengoechea at Queen’s University Belfast, is aimed at undertaking a multidisciplinary… Read more

Fully funded PhD position in Biopharmaceutical development for pulmonary delivery; Industrial Collaboration

This cross-disciplinary PhD project is between the School of Biomedical Science at UWL and the School of Pharmacy at UCL, and Pharmaceutical company to investigate the feasibility of developing an inhalation form of biotherapeutics for severe chronic inflammatory diseases. Read more

The BCAT1 CXXC Motif and Oncogenesis in Acute Myeloid Leukaemia

The BCAT1 gene is implicated in the pathogenesis of many cancer types, including acute myeloid leukaemia (AML)1–4. Recently, our group identified a novel antioxidant role for BCAT1 in AML cells5. Read more

Fully Funded PhD Scholarship in Polarised Fluorescence based Downstream Analytics, NBL-1

Application(s) are invited from suitably qualified candidates for full-time funded PhD scholarship(s) starting in February 2024 affiliated to the Nanoscale Biophotonics Laboratory in the Discipline of Physics (School of Natural Sciences) at the University of Galway. Read more

Role of BTG1 and BTG2 in acute lymphocytic leukaemia and diffuse large B-cell lymphoma

Acute lymphocytic leukaemia (ALL) and diffuse large B-cell lymphoma (DLBCL) is often associated with small deletions of or point mutations in the highly related BTG1 or BTG2 genes. Read more

Development of antibody-drug conjugates (ADCs) for oncology indications

  Research Group: Institute of Cancer Therapeutics
A major challenge in cancer therapy is to develop therapeutic agents that selectively target tumour cells but are not harmful to normal tissue. Read more

Structural and functional characterisation of MALT1 ubiquitination to aid in the development of novel anti-cancer therapies

Nuclear factor-kappa B (NF-kB) is a family of transcription factors that play a crucial role in regulating various cellular processes; primarily related to immune responses, inflammation, and cell survival. Read more

Developing the next generation of broad-spectrum antiviral polymers

Applications are invited for a funded PhD position in the School of Chemistry at the University of Birmingham. The School of Chemistry is keen to achieve a gender and diversity balance across the School and welcomes applicants from all backgrounds. Read more

Filtering Results